1. Home
  2. ELUT vs CSBR Comparison

ELUT vs CSBR Comparison

Compare ELUT & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • CSBR
  • Stock Information
  • Founded
  • ELUT 2015
  • CSBR 1985
  • Country
  • ELUT United States
  • CSBR United States
  • Employees
  • ELUT N/A
  • CSBR N/A
  • Industry
  • ELUT Medical Specialities
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ELUT Health Care
  • CSBR Health Care
  • Exchange
  • ELUT Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • ELUT 128.3M
  • CSBR 151.0M
  • IPO Year
  • ELUT 2020
  • CSBR 1986
  • Fundamental
  • Price
  • ELUT $3.22
  • CSBR $10.17
  • Analyst Decision
  • ELUT Strong Buy
  • CSBR Strong Buy
  • Analyst Count
  • ELUT 2
  • CSBR 1
  • Target Price
  • ELUT $10.00
  • CSBR $8.00
  • AVG Volume (30 Days)
  • ELUT 37.7K
  • CSBR 46.1K
  • Earning Date
  • ELUT 03-06-2025
  • CSBR 03-11-2025
  • Dividend Yield
  • ELUT N/A
  • CSBR N/A
  • EPS Growth
  • ELUT N/A
  • CSBR N/A
  • EPS
  • ELUT N/A
  • CSBR N/A
  • Revenue
  • ELUT $24,782,000.00
  • CSBR $53,571,000.00
  • Revenue This Year
  • ELUT $3.88
  • CSBR $14.19
  • Revenue Next Year
  • ELUT $34.52
  • CSBR $10.11
  • P/E Ratio
  • ELUT N/A
  • CSBR N/A
  • Revenue Growth
  • ELUT N/A
  • CSBR 7.19
  • 52 Week Low
  • ELUT $2.28
  • CSBR $3.60
  • 52 Week High
  • ELUT $5.24
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 55.09
  • CSBR 48.12
  • Support Level
  • ELUT $2.83
  • CSBR $10.32
  • Resistance Level
  • ELUT $3.00
  • CSBR $11.33
  • Average True Range (ATR)
  • ELUT 0.26
  • CSBR 0.99
  • MACD
  • ELUT 0.09
  • CSBR -0.20
  • Stochastic Oscillator
  • ELUT 91.01
  • CSBR 29.57

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: